Transgene Biotek [TRABI] vs Zota Health Care [ZOTA] Detailed Stock Comparison

Transgene Biotek

BSE
Loading...

Zota Health Care

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Transgene Biotek wins in 7 metrics, Zota Health Care wins in 11 metrics, with 0 ties. Zota Health Care appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricTransgene BiotekZota Health CareBetter
P/E Ratio (TTM)-48.67-70.48Zota Health Care
Price-to-Book Ratio3.0418.81Transgene Biotek
Debt-to-Equity Ratio144.770.61Zota Health Care
PEG Ratio0.16-28.19Zota Health Care
EV/EBITDA-47.44-1,153.41Zota Health Care
Profit Margin (TTM)100.00%-17.04%Transgene Biotek
Operating Margin (TTM)-380.20%-10.35%Zota Health Care
Return on Equity-6.74%-24.83%Transgene Biotek
Return on Assets (TTM)-0.47%-12.84%Transgene Biotek
Free Cash Flow (TTM)$-5.04M$-959.42MTransgene Biotek
Dividend YieldN/A0.11%N/A
1-Year Return-43.99%120.72%Zota Health Care
Price-to-Sales Ratio (TTM)116.7011.16Zota Health Care
Enterprise Value$415.59M$42.27BZota Health Care
EV/Revenue Ratio159.2314.43Zota Health Care
Gross Profit Margin (TTM)100.00%56.43%Transgene Biotek
Revenue per Share (TTM)$0$122Zota Health Care
Earnings per Share (Diluted)$-0.18$-20.86Transgene Biotek
Beta (Stock Volatility)0.800.44Zota Health Care
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Transgene Biotek vs Zota Health Care Stock Performance Analysis

Loading Price Chart...

Transgene Biotek
Zota Health Care
Transgene Biotek Stock Overview | Zota Health Care Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Transgene Biotek-9.82%14.66%-1.13%1.86%14.06%-28.78%
Zota Health Care1.04%-2.82%7.26%53.28%88.37%82.85%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Transgene Biotek-43.99%36.45%-0.45%48.98%-91.63%-95.45%
Zota Health Care120.72%361.23%898.97%1,503.59%1,503.59%1,503.59%

News Based Sentiment: Transgene Biotek vs Zota Health Care

Transgene Biotek

News based Sentiment: NEGATIVE

The initiation of insolvency proceedings is a game-changing event for Transgene Biotek Ltd., significantly increasing the risk for investors. Coupled with consistent losses and a declining market cap, the company faces a very uncertain future, making this a critical month for its investment story.

View Transgene Biotek News Sentiment Analysis

Zota Health Care

News based Sentiment: MIXED

September presented a mixed bag for Zota Health Care, with strong revenue growth and a rising market cap countered by declining operating profits and a negative EBITDA. The company is actively raising capital, but its profitability remains a key concern, making it a high-risk, high-reward investment.

View Zota Health Care News Sentiment Analysis

Performance & Financial Health Analysis: Transgene Biotek vs Zota Health Care

MetricTRABIZOTA
Market Information
Market Cap i₹335.38M₹40.90B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i95,533132,703
90 Day Avg. Volume i53,16798,858
Last Close₹3.95₹1,472.60
52 Week Range₹3.22 - ₹7.71₹535.00 - ₹1,555.00
% from 52W High-48.77%-5.30%
All-Time High₹322.50 (Jan 23, 2006)₹1,555.00 (Sep 15, 2025)
% from All-Time High-98.78%-5.30%
Growth Metrics
Quarterly Revenue Growth0.00%0.84%
Quarterly Earnings Growth0.01%0.84%
Financial Health
Profit Margin (TTM) i1.00%-0.17%
Operating Margin (TTM) i-3.80%-0.10%
Return on Equity (TTM) i-0.07%-0.25%
Debt to Equity (MRQ) i144.770.61
Cash & Liquidity
Book Value per Share (MRQ)₹1.32₹78.12
Cash per Share (MRQ)₹0.04N/A
Operating Cash Flow (TTM) i₹1.93M₹-1,007,999,000
Levered Free Cash Flow (TTM) i₹-6,761,000₹-563,984,000
Dividends
Last 12-Month Dividend Yield iN/A0.11%
Last 12-Month Dividend iN/A₹1.00

Valuation & Enterprise Metrics Analysis: Transgene Biotek vs Zota Health Care

MetricTRABIZOTA
Price Ratios
P/E Ratio (TTM) i-48.67-70.48
Forward P/E iN/AN/A
PEG Ratio i0.16-28.19
Price to Sales (TTM) i116.7011.16
Price to Book (MRQ) i3.0418.81
Market Capitalization
Market Capitalization i₹335.38M₹40.90B
Enterprise Value i₹415.59M₹42.27B
Enterprise Value Metrics
Enterprise to Revenue i159.2314.43
Enterprise to EBITDA i-47.44-1,153.41
Risk & Other Metrics
Beta i0.800.44
Book Value per Share (MRQ) i₹1.32₹78.12

Financial Statements Comparison: Transgene Biotek vs Zota Health Care

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)TRABIZOTA
Revenue/Sales i₹765,000₹1.04B
Cost of Goods Sold i₹0₹451.33M
Gross Profit i₹765,000₹584.50M
Research & Development iN/AN/A
Operating Income (EBIT) i₹-5.66M₹-107.17M
EBITDA i₹-4.98M₹48.28M
Pre-Tax Income i₹-7.13M₹-130.85M
Income Tax i₹0₹6.93M
Net Income (Profit) i₹-7.13M₹-137.78M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)TRABIZOTA
Cash & Equivalents i₹2.84M₹21.32M
Total Current Assets i₹12.64M₹1.84B
Total Current Liabilities i₹127.38M₹1.01B
Long-Term Debt i₹61.03M₹1.08B
Total Shareholders Equity i₹100.30M₹2.27B
Retained Earnings iN/AN/A
Property, Plant & Equipment i₹32.85M₹1.81B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)TRABIZOTA
Operating Cash Flow iN/A₹-8.57M
Capital Expenditures iN/A₹-982,011
Free Cash Flow iN/A₹41.94M
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricTRABIZOTA
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i95,533132,703
Average Daily Volume (90 Day) i53,16798,858
Shares Outstanding i75.77M25.85M
Float Shares i48.28M12.58M
% Held by Insiders i0.22%0.00%
% Held by Institutions i0.00%0.00%

Dividend Analysis & Yield Comparison: Transgene Biotek vs Zota Health Care

MetricTRABIZOTA
Last 12-Month Dividend iN/A₹1.00
Last 12-Month Dividend Yield iN/A0.11%
3-Year Avg Annual Dividend iN/A₹1.17
3-Year Avg Dividend Yield iN/A0.30%
3-Year Total Dividends iN/A₹3.50
Ex-Dividend DateN/ASep 20, 2024